Xenohelix

제노헬릭스

Incheon, South Korea · Founded 2019

Headquarters
Incheon
Employees
11–50
Founded
2019
Business Model
B2B
Last Round
SeedSep 2019
Rounds
1

About

Xenohelix (제노헬릭스) is a South Korean biotech company specializing in small RNA (sRNA) platform technology for molecular diagnostics and research. The company develops ultra-sensitive RNA detection platforms including XENOPURE for high-purity RNA extraction and XENO-Q for single-base-pair precision diagnostics, targeting conditions such as Parkinson's disease and fatty liver disease. Its technology enables non-invasive, blood-based early diagnosis as an alternative to expensive conventional tests, and the company also offers cosmetic products derived from natural exosomes.

Summary

Xenohelix is a Biotech company based in Incheon, South Korea, founded in 2019. Its most recent funding was a Seed round in Sep 2019. Investors include KB Investment and Partners Investment.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundSep 2019

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Xenohelix on Indexed.vc
<a href="https://indexed.vc/companies/xenohelix"><img src="https://indexed.vc/api/badge/company/xenohelix" alt="Xenohelix on Indexed.vc" width="260" height="76" /></a>